Beibei Wang Selected Research

Chlamydophila Infections

1/2022	Chlamydia pneumoniae Infection Induces Vascular Smooth Muscle Cell Migration and Atherosclerosis Through Mitochondrial Reactive Oxygen Species-Mediated JunB-Fra-1 Activation.
12/2019	Chlamydia pneumoniae infection promotes vascular smooth muscle cell migration via c-Fos/interleukin-17C signaling.
1/2018	Chlamydia pneumoniae infection promotes monocyte transendothelial migration by increasing vascular endothelial cell permeability via the tyrosine phosphorylation of VE-cadherin.
5/2015	Berberine inhibits Chlamydia pneumoniae infection-induced vascular smooth muscle cell migration through downregulating MMP3 and MMP9 via PI3K.
12/2013	Chlamydia pneumoniae infection promotes vascular smooth muscle cell migration through a Toll-like receptor 2-related signaling pathway.
11/2012	Chlamydophila (Chlamydia) pneumoniae infection promotes vascular smooth muscle cell adhesion and migration through IQ domain GTPase-activating protein 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Beibei Wang Research Topics

Disease

36	Neoplasms (Cancer) 01/2022 - 02/2003
19	Infections 01/2022 - 12/2013
16	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2005
12	Inflammation (Inflammations) 01/2022 - 07/2013
8	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2012
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2005
6	Chlamydophila Infections 01/2022 - 11/2012
5	Atherosclerosis 01/2022 - 01/2020
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2018 - 09/2005
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2017 - 07/2013
4	Acute Lung Injury 01/2021 - 04/2019
4	Colorectal Neoplasms (Colorectal Cancer) 02/2020 - 01/2018
4	Demyelinating Diseases (Demyelinating Disease) 01/2018 - 01/2016
3	Bacterial Infections (Bacterial Infection) 01/2022 - 08/2021
3	Disease Progression 01/2022 - 12/2009
3	Ulcerative Colitis 01/2022 - 01/2021
3	COVID-19 01/2022 - 11/2020
3	Obesity 07/2021 - 01/2017
3	Multiple Sclerosis 01/2016 - 07/2013
2	Lung Injury 04/2022 - 10/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2022 - 09/2015
2	Lung Diseases (Lung Disease) 04/2022 - 10/2019
2	Carcinoma (Carcinomatosis) 01/2022 - 10/2005
2	Edema (Dropsy) 01/2021 - 06/2019
2	Fibrosis (Cirrhosis) 01/2021 - 01/2017
2	Lymphatic Metastasis 01/2021 - 03/2008
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2019 - 05/2008
2	Sepsis (Septicemia) 01/2017 - 12/2016
2	Lung Neoplasms (Lung Cancer) 05/2016 - 03/2014
2	Neuroinflammatory Diseases 01/2016 - 07/2013
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 06/2022
1	Adenocarcinoma in Situ 04/2022
1	Adenocarcinoma 04/2022
1	Adenocarcinoma of Lung 04/2022

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2005
8	Cisplatin (Platino)FDA LinkGeneric 03/2021 - 10/2005
7	Messenger RNA (mRNA)IBA 11/2021 - 01/2005
6	CytokinesIBA 04/2022 - 01/2016
5	Long Noncoding RNAIBA 01/2022 - 11/2019
5	Estrogen ReceptorsIBA 01/2022 - 02/2018
5	Biological ProductsIBA 09/2021 - 01/2007
5	Histone Deacetylase InhibitorsIBA 01/2020 - 09/2005
4	MicroRNAs (MicroRNA)IBA 04/2022 - 01/2017
4	Particulate MatterIBA 04/2022 - 01/2020
4	CalciumIBA 01/2022 - 01/2018
4	Phosphotransferases (Kinase)IBA 01/2022 - 10/2005
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 11/2019
4	EnzymesIBA 01/2022 - 03/2012
4	LipopolysaccharidesIBA 01/2021 - 12/2016
4	UbiquitinIBA 03/2020 - 01/2013
3	Apolipoproteins E (ApoE)IBA 01/2022 - 12/2019
3	Antiviral Agents (Antivirals)IBA 01/2022 - 12/2009
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
3	LipidsIBA 01/2022 - 02/2011
3	Estrogens (Estrogen)FDA Link 01/2022 - 02/2018
3	epsinIBA 01/2021 - 01/2020
3	Peptides (Polypeptides)IBA 11/2020 - 01/2016
3	Angiopoietin-1IBA 01/2018 - 01/2016
3	C16 peptideIBA 01/2018 - 07/2013
3	Pharmaceutical PreparationsIBA 01/2017 - 01/2013
3	trichostatin A (A 300)IBA 01/2013 - 09/2005
3	theasinensin AIBA 01/2013 - 09/2005
2	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2022 - 12/2013
2	Pattern Recognition ReceptorsIBA 06/2022 - 01/2022
2	IonsIBA 01/2022 - 12/2021
2	MetalsIBA 01/2022 - 09/2019
2	AntioxidantsIBA 01/2022 - 03/2021
2	AntibodiesIBA 01/2022 - 10/2020
2	oxidized low density lipoproteinIBA 01/2022 - 02/2011
2	Chalcone (Benzalacetophenone)IBA 01/2021 - 06/2019
2	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2019
2	Interleukin-17 (Interleukin 17)IBA 11/2020 - 12/2019
2	Ligases (Synthetase)IBA 03/2020 - 04/2019
2	tocophersolanIBA 02/2020 - 01/2018
2	CholesterolIBA 01/2020 - 02/2011
2	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2017
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2019 - 05/2016
2	Hematoxylin (Haematoxylon)IBA 11/2019 - 06/2019
2	Eosine Yellowish-(YS) (Eosin)IBA 11/2019 - 06/2019
2	Mitochondrial Proteins (Mitochondrial Protein)IBA 09/2019 - 01/2017
2	Tamoxifen FDA LinkGeneric 04/2019 - 02/2018
2	Estrogen Receptor alphaIBA 04/2019 - 02/2018
2	Neutralizing AntibodiesIBA 01/2019 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2014
2	IntegrinsIBA 01/2016 - 07/2013
2	Liposomes (Liposome)IBA 12/2015 - 07/2005
2	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 02/2014 - 12/2013
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 02/2011 - 01/2011
1	AntigensIBA 06/2022
1	Endoplasmic Reticulum Chaperone BiPIBA 04/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2022
1	ConnexinsIBA 01/2022

Therapy/Procedure

19	Therapeutics 04/2022 - 10/2007
10	Drug Therapy (Chemotherapy) 01/2022 - 03/2012
4	Transplantation 10/2019 - 05/2008
3	Punctures 01/2017 - 10/2015
3	Ligation 01/2017 - 10/2015
2	Photothermal Therapy 02/2020 - 01/2018